China Shineway Pharmaceutical Group (HKG:2877) recorded a turnover of 2.89 billion yuan for the nine months ended Sept. 30, down 16.9% from the year-ago period, a Friday filing said.
The pharmaceutical company's injection, soft capsule, granule, and TCM formula granule products accounted for around 35.6%, 13.5%, 15.8%, and 28.5%, respectively, of the total turnover.
The company's shares were down over 1% in recent trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments